- Home
- Publications
- Publication Search
- Publication Details
Title
Gene Therapy of Sphingolipid Metabolic Disorders
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 4, Pages 3627
Publisher
MDPI AG
Online
2023-02-13
DOI
10.3390/ijms24043627
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chaperone Therapy in Fabry Disease
- (2022) Frank Weidemann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access
- (2022) Francesca Fumagalli et al. LANCET
- AAV9-coGLB1 Improves Lysosomal Storage and Rescues Central Nervous System Inflammation in a Mutant Mouse Model of GM1 Gangliosidosis
- (2022) Sichi Liu et al. CURRENT GENE THERAPY
- Spinal muscular atrophy and the world’s most expensive medicines: The price of life
- (2022) Arthur G. Green DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- “Atypical” Krabbe disease in two siblings harboring biallelic GALC mutations including a deep intronic variant
- (2022) Francesco Nicita et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Efficacy and Safety of a Krabbe Disease Gene Therapy
- (2022) Juliette Hordeaux et al. HUMAN GENE THERAPY
- Current Strategies for the Gene Therapy of Autosomal Recessive Congenital Ichthyosis and Other Types of Inherited Ichthyosis
- (2022) Daria S. Chulpanova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Making Decisions About Krabbe Disease Newborn Screening
- (2022) Samantha A. Schrier Vergano et al. PEDIATRICS
- Gene and Cell Therapy for Epilepsy: A Mini Review
- (2022) Alisa A. Shaimardanova et al. Frontiers in Molecular Neuroscience
- Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders
- (2022) Shaza S. Issa et al. Frontiers in Pharmacology
- Phenotype Expansion for Atypical Gaucher Disease Due to Homozygous Missense PSAP Variant in a Large Consanguineous Pakistani Family
- (2022) Khurram Liaqat et al. Genes
- Identification of a novel therapeutic target underlying atypical manifestation of Gaucher disease
- (2022) Eun Na Kim et al. Clinical and Translational Medicine
- Valoctocogene Roxaparvovec: First Approval
- (2022) Hannah A. Blair DRUGS
- CLN3 is required for the clearance of glycerophosphodiesters from lysosomes
- (2022) Nouf N. Laqtom et al. NATURE
- Spns1 is a lysophospholipid transporter mediating lysosomal phospholipid salvage
- (2022) Menglan He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)
- (2022) Derralynn A. Hughes et al. Journal of Clinical Medicine
- AAVrh10 vector corrects pathology in animal models of GM1 gangliosidosis and achieves widespread distribution in the CNS of nonhuman primates
- (2022) Michaël Hocquemiller et al. Molecular Therapy-Methods & Clinical Development
- Global Incidence and Prevalence of Gaucher Disease: A Targeted Literature Review
- (2022) Genaro Castillon et al. Journal of Clinical Medicine
- Lentivirus-mediated gene therapy for Fabry disease
- (2021) Aneal Khan et al. Nature Communications
- One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency
- (2021) George A. Diaz et al. GENETICS IN MEDICINE
- Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit
- (2021) Meaghan Van Alstyne et al. NATURE NEUROSCIENCE
- Krabbe disease: New hope for an old disease
- (2021) Allison M. Bradbury et al. NEUROSCIENCE LETTERS
- Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development
- (2021) Giulia Massaro et al. Biomolecules
- α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice
- (2021) Julen Rodríguez-Castejón et al. Pharmaceutics
- Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain
- (2021) Xintao Zhang et al. BIOMATERIALS
- Functionality of a bicistronic construction containing HEXA and HEXB genes encoding β-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses
- (2021) AlbertA Rizvanov et al. Neural Regeneration Research
- Therapeutic Approaches in Lysosomal Storage Diseases
- (2021) Carlos Fernández-Pereira et al. Biomolecules
- Serum Cytokine Profile, Beta-Hexosaminidase A Enzymatic Activity and GM2 Ganglioside Levels in the Plasma of a Tay-Sachs Disease Patient after Cord Blood Cell Transplantation and Curcumin Administration: A Case Report
- (2021) Alisa A. Shaimardanova et al. Life-Basel
- SnapShot: Lysosomal Storage Diseases
- (2020) José A. Martina et al. CELL
- Developments in the treatment of Fabry disease
- (2020) Sanne J. Veen et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies
- (2020) Rachel M. Bailey et al. BRAIN RESEARCH
- Abnormal epiphyseal development in a feline model of Sandhoff disease
- (2020) Margaret A. McNulty et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- A Large‐Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands.
- (2020) Jonas M. Heijer et al. MOVEMENT DISORDERS
- Translational Feasibility of Lumbar Puncture for Intrathecal AAV Administration
- (2020) Christian Hinderer et al. Molecular Therapy-Methods & Clinical Development
- Therapeutic benefit after intracranial gene therapy delivered during the symptomatic stage in a feline model of Sandhoff disease
- (2020) Victoria J. McCurdy et al. GENE THERAPY
- A single injection of an optimized AAV vector into cerebrospinal fluid corrects neurological disease in a murine model of GM1 gangliosidosis
- (2020) Christian Hinderer et al. HUMAN GENE THERAPY
- Adeno‐associated virus serotype 1‐based gene therapy for FTD caused by GRN mutations
- (2020) Christian Hinderer et al. Annals of Clinical and Translational Neurology
- AAV2/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate Reduction
- (2020) Makiko Yasuda et al. Molecular Therapy-Methods & Clinical Development
- Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches
- (2020) Alisa A. Shaimardanova et al. Frontiers in Medicine
- Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector
- (2020) Maria Dahl et al. Molecular Therapy-Methods & Clinical Development
- Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease
- (2020) Isabel C. Yoon et al. BLOOD
- Lysosomal storage disorders – challenges, concepts and avenues for therapy: beyond rare diseases
- (2019) André R. A. Marques et al. JOURNAL OF CELL SCIENCE
- La maladie de Gaucher : quand y penser ?
- (2019) Y. Nguyen et al. REVUE DE MEDECINE INTERNE
- Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months
- (2019) Maria L. Beltran-Quintero et al. Orphanet Journal of Rare Diseases
- Impact of age and motor function in a phase 1/2A study of infants with SMA Type 1 receiving single-dose gene replacement therapy
- (2019) Linda P. Lowes et al. PEDIATRIC NEUROLOGY
- AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophy
- (2019) Rithu Pattali et al. GENE THERAPY
- Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase Activity
- (2019) John Marshall et al. MOLECULAR THERAPY
- Saposin B–Deficient Metachromatic Leukodystrophy Mimicking Acute Flaccid Paralysis
- (2019) Priyanka Madaan et al. NEUROPEDIATRICS
- Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
- (2019) Allison M. Keeler et al. Annual Review of Virology
- GBA1-associated parkinsonism
- (2019) Emory Ryan et al. CURRENT OPINION IN NEUROLOGY
- Intrathecal AAVrh10 corrects Biochemical and Histological Hallmarks of Mucopolysaccharidosis VII Mice and Improves Behavior and Survival
- (2019) G Pagès et al. HUMAN MOLECULAR GENETICS
- Adeno-associated viral vector serotype 9–based gene therapy for Niemann-Pick disease type A
- (2019) Lluis Samaranch et al. Science Translational Medicine
- P1516Novel cardiotropic AAV variant C102 vectors show superior gene delivery & reduced immunogenicity in non-human primates, transduction of human cardiomyocytes, & correction of Fabry disease phenotype
- (2019) M Kotterman et al. EUROPEAN HEART JOURNAL
- Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy
- (2019) Renato Santos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants
- (2019) Silvia Lombardi et al. RNA Biology
- Production and Application of Multicistronic Constructs for Various Human Disease Therapies
- (2019) Alisa A. Shaimardanova et al. Pharmaceutics
- Genetics and Therapies for GM2 Gangliosidosis
- (2018) Maria Begona Cachon-Gonzalez et al. CURRENT GENE THERAPY
- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- AAVrh10 Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease)
- (2018) Allison M. Bradbury et al. HUMAN GENE THERAPY
- Acid ceramidase deficiency: Farber disease and SMA-PME
- (2018) Fabian P. S. Yu et al. Orphanet Journal of Rare Diseases
- Delivery of Gba Gene Using AAV9 Vector Therapy as a Treatment Strategy in Mouse Models of Gaucher disease
- (2018) Sichen Du et al. HUMAN GENE THERAPY
- A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life
- (2018) Nicholas Bascou et al. Orphanet Journal of Rare Diseases
- Clinical presentation and outcome in infantile Sandhoff disease: a case series of 25 patients from Iranian neurometabolic bioregistry with five novel mutations
- (2018) Ali Reza Tavasoli et al. Orphanet Journal of Rare Diseases
- New Approaches to Tay-Sachs Disease Therapy
- (2018) Valeriya V. Solovyeva et al. Frontiers in Physiology
- Lysosomal storage diseases
- (2018) Frances M. Platt et al. Nature Reviews Disease Primers
- A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
- (2017) Jérôme Stirnemann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Types A and B Niemann-Pick disease
- (2017) Edward H. Schuchman et al. MOLECULAR GENETICS AND METABOLISM
- Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications
- (2017) Alessandra Biffi MOLECULAR THERAPY
- Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises
- (2017) Fedah E. Mohamed et al. Frontiers in Pharmacology
- Clinical, biochemical and molecular characterization of prosaposin deficiency
- (2016) M. Motta et al. CLINICAL GENETICS
- Adeno-Associated Virus Gene Therapy for Liver Disease
- (2016) Lisa M. Kattenhorn et al. HUMAN GENE THERAPY
- Krabbe disease: One Hundred years from the bedside to the bench to the bedside
- (2016) David A. Wenger et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Neuroimmune mechanisms in Krabbe's disease
- (2016) Gregory B. Potter et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Clinical management of Krabbe disease
- (2016) Maria L. Escolar et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Gene therapy for metachromatic leukodystrophy
- (2016) Jonathan B. Rosenberg et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
- (2016) Maria Sessa et al. LANCET
- AAV-Mediated Gene Delivery in a Feline Model of Sandhoff Disease Corrects Lysosomal Storage in the Central Nervous System
- (2015) Hannah E. Rockwell et al. ASN Neuro
- Structure of neurotropic adeno-associated virus AAVrh.8
- (2015) Sujata Halder et al. JOURNAL OF STRUCTURAL BIOLOGY
- Mucopolysaccharidosis-like phenotype in feline Sandhoff disease and partial correction after AAV gene therapy
- (2015) Heather L. Gray-Edwards et al. MOLECULAR GENETICS AND METABOLISM
- Glybera's Second Act: The Curtain Rises on the High Cost of Therapy
- (2015) Seppo Ylä-Herttuala MOLECULAR THERAPY
- Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates
- (2015) Michel Zerah et al. Human Gene Therapy Clinical Development
- Evaluation of Aminoglycoside and Non-Aminoglycoside Compounds for Stop-Codon Readthrough Therapy in Four Lysosomal Storage Diseases
- (2015) Marta Gómez-Grau et al. PLoS One
- Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease
- (2014) V J McCurdy et al. GENE THERAPY
- Chaperone Therapy for GM2 Gangliosidosis: Effects of Pyrimethamine on β-Hexosaminidase Activity in Sandhoff Fibroblasts
- (2013) Elena Chiricozzi et al. MOLECULAR NEUROBIOLOGY
- Therapeutic Response in Feline Sandhoff Disease Despite Immunity to Intracranial Gene Therapy
- (2013) Allison M Bradbury et al. MOLECULAR THERAPY
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- (2013) A. Biffi et al. SCIENCE
- Lessons Learned from the Clinical Development and Market Authorization of Glybera
- (2013) Laura M. Bryant et al. Human Gene Therapy Clinical Development
- The advent of AAV9 expands applications for brain and spinal cord gene delivery
- (2012) Robert D Dayton et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Correction of Brain Oligodendrocytes by AAVrh.10 Intracerebral Gene Therapy in Metachromatic Leukodystrophy Mice
- (2012) Françoise Piguet et al. HUMAN GENE THERAPY
- Long-Term Expression and Safety of Administration of AAVrh.10hCLN2 to the Brain of Rats and Nonhuman Primates for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis
- (2012) Dolan Sondhi et al. Human Gene Therapy Methods
- Adeno-associated virus-mediated expression of β-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain
- (2011) Timothy J. Sargeant et al. HUMAN MOLECULAR GENETICS
- High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice
- (2011) Jin Hee Kim et al. PLoS One
- Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy
- (2010) C. i Dali et al. NEUROLOGY
- Fabry disease
- (2010) Dominique P Germain Orphanet Journal of Rare Diseases
- Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): Report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations
- (2009) Ladislav Kuchař et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Metachromatic leukodystrophy - mutation analysis provides further evidence of genotype-phenotype correlation
- (2009) A Biffi et al. CLINICAL GENETICS
- Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate
- (2009) M.-A. Colle et al. HUMAN MOLECULAR GENETICS
- Characterization of new arylsulfatase A gene mutations reinforces genotype-phenotype correlation in metachromatic leukodystrophy
- (2009) Martina Cesani et al. HUMAN MUTATION
- Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
- (2009) N. Cartier et al. SCIENCE
- Chemical chaperone therapy for GM1-gangliosidosis
- (2008) Y. Suzuki CELLULAR AND MOLECULAR LIFE SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation